A free and tailored microRNA seminar at your venue
MicroRNA research grows exponentially
MicroRNAs (miRNAs) constitute a relatively new class of tissue specific, small non-coding RNAs, which regulate the expression of up to 30% of all genes, and are involved in many biological processes, including carcinogenesis. Last year alone (2008), nearly 1300 microRNA papers were published (source: PubMed).
Exiqon is a global source of valuable microRNA research knowledge
Exiqon is a pioneer in the field of microRNA research. Today, we have global activities in three business areas where our proprietary Locked Nucleic Acid (LNA™) technology provides a competitive advantage.
- Exiqon Life Sciences markets the popular LNA™-based tools for small RNA research.
- Exiqon Pharma Services works with pharmaceutical companies to characterize new anti-cancer drugs in human tumors using a customized extreme drug resistance assay.
- Exiqon Diagnostics is a market leader in the field of in vitro treatment selection testing for cancer, and performs innovative microRNA research aimed at rapidly identifying new cancer diagnostics.
Tap into the combined knowledge of Exiqon – for free
We are happy to meet with you and your colleagues to discuss any microRNA research topic of interest to you. For inspiration, we have created a list of microRNA topics that might be of interest to you. Or, we can address any other microRNA topic.
Please check the topics of interest from the list below and fill in your contact details: